Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Claudia Lennicke, Jette Rahn, Jürgen Bukur, Falko Hochgräfe, Ludger A. Wessjohann, Rudolf Lichtenfels & Barbara Seliger. (2017) Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid. OncoImmunology 6:6.
Read now
Read now
Barbara Seliger, Matthias Kloor & Soldano Ferrone. (2017) HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance. OncoImmunology 6:2.
Read now
Read now
Articles from other publishers (27)
Teng Fang, Hao Sun, Xiyue Sun, Yi He, Peixia Tang, Lixin Gong, Zhen Yu, Lanting Liu, Shiyi Xie, Tingyu Wang, Zhenshu Xu, Shuhua Yi, Gang An, Yan Xu, Guoqing Zhu, Lugui Qiu & Mu Hao. (2023) Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma. Blood Science 5:3, pages 196-208.
Crossref
Crossref
Filippo Ugolini, Anna Szumera-Ciećkiewicz, Gianna Baroni, Gabriella Nesi, Mario Mandalà, Soldano Ferrone & Daniela Massi. (2022) Differential HLA class I subunit (A, B, C heavy chain and β2-microglobulin) expression levels in normal tissues. Virchows Archiv 482:2, pages 359-368.
Crossref
Crossref
James J. Kang, Albert Ko, Sang Hoon Kil, Jon Mallen-St. Clair, Daniel Sanghoon Shin, Marilene B. Wang & Eri S. Srivatsan. (2023) EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:1, pages 188827.
Crossref
Crossref
Valentina N. Mal’tseva, Michael V. Goltyaev, Egor A. Turovsky & Elena G. Varlamova. (2022) Immunomodulatory and Anti-Inflammatory Properties of Selenium-Containing Agents: Their Role in the Regulation of Defense Mechanisms against COVID-19. International Journal of Molecular Sciences 23:4, pages 2360.
Crossref
Crossref
Sean P. Korpela, Trista K. Hinz, Ayman Oweida, Jihye Kim, Jacob Calhoun, Robert Ferris, Raphael A. Nemenoff, Sana D. Karam, Eric T. Clambey & Lynn E. Heasley. (2021) Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response. Journal of Translational Medicine 19:1.
Crossref
Crossref
Shogo Kumagai, Shohei Koyama & Hiroyoshi Nishikawa. (2021) Antitumour immunity regulated by aberrant ERBB family signalling. Nature Reviews Cancer 21:3, pages 181-197.
Crossref
Crossref
Johanna Bödder, Tasmin Zahan, Rianne van Slooten, Gerty Schreibelt, I. Jolanda M. de Vries & Georgina Flórez-Grau. (2021) Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer. Frontiers in Immunology 11.
Crossref
Crossref
Diana Bell, Achim Bell, Renata Ferrarotto, Bonnie Glisson, Yoko Takahashi, Gregory Fuller, Randal Weber & Ehab Hanna. (2020) High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Annals of Diagnostic Pathology 49, pages 151622.
Crossref
Crossref
Shilpa Raghuvanshi Chauhan, Pallavi G. Singhal, Upma Sharma, Kapil Bandil, Kausik Chakraborty & Mausumi Bharadwaj. (2019) Th9 cytokines curb cervical cancer progression and immune evasion. Human Immunology 80:12, pages 1020-1025.
Crossref
Crossref
Ana Bela Sarmento-Ribeiro, Andreas Scorilas, Ana Cristina Gonçalves, Thomas Efferth & Ioannis P. Trougakos. (2019) The emergence of drug resistance to targeted cancer therapies: Clinical evidence. Drug Resistance Updates 47, pages 100646.
Crossref
Crossref
Michael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, Karthikeyan Subbarayan, Chiara Massa, Sandy Tretbar, Anja Mueller, Diana Handke, Katharina Biehl, Jürgen Bukur, Marco Donia, Ofer Mandelboim & Barbara Seliger. (2019) Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy. Cancer Immunology, Immunotherapy 68:10, pages 1689-1700.
Crossref
Crossref
Michal Harel, Rona Ortenberg, Siva Karthik Varanasi, Kailash Chandra Mangalhara, Mariya Mardamshina, Ettai Markovits, Erez N. Baruch, Victoria Tripple, May Arama-Chayoth, Eyal Greenberg, Anjana Shenoy, Ruveyda Ayasun, Naama Knafo, Shihao Xu, Liat Anafi, Gali Yanovich-Arad, Georgina D. Barnabas, Shira Ashkenazi, Michal J. Besser, Jacob Schachter, Marcus Bosenberg, Gerald S. Shadel, Iris Barshack, Susan M. Kaech, Gal Markel & Tamar Geiger. (2019) Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence. Cell 179:1, pages 236-250.e18.
Crossref
Crossref
Clement Chung. (2018) To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade. Journal of Oncology Pharmacy Practice 25:3, pages 663-673.
Crossref
Crossref
Jake S. O’Donnell, Michele W. L. Teng & Mark J. Smyth. (2018) Cancer immunoediting and resistance to T cell-based immunotherapy. Nature Reviews Clinical Oncology 16:3, pages 151-167.
Crossref
Crossref
Chong Sun, Riccardo Mezzadra & Ton N. Schumacher. (2018) Regulation and Function of the PD-L1 Checkpoint. Immunity 48:3, pages 434-452.
Crossref
Crossref
Ronald J. Fecek, Subhara Raveendran, Manoj Chelvanambi & Walter J. Storkus. 2018. Heat Shock Proteins in the Immune System. Heat Shock Proteins in the Immune System
157
180
.
Wentao Yu, Hong Qu, Guangming Cao, Chongdong Liu, Haiteng Deng & Zhenyu Zhang. (2017) MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer. Biochemical and Biophysical Research Communications 494:1-2, pages 13-19.
Crossref
Crossref
Barbara Seliger. (2017) Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors. Cytokine & Growth Factor Reviews 36, pages 49-56.
Crossref
Crossref
Peter L. Stern. (2017) Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12–13 May 2017. Therapeutic Advances in Vaccines 5:3, pages 55-68.
Crossref
Crossref
Peter J. Stambrook, John Maher & Farzin Farzaneh. (2017) Cancer Immunotherapy: Whence and Whither. Molecular Cancer Research 15:6, pages 635-650.
Crossref
Crossref
Claire K. S. Meikle, Clare A. Kelly, Priyanka Garg, Leah M. Wuescher, Ramadan A. Ali & Randall G. Worth. (2017) Cancer and Thrombosis: The Platelet Perspective. Frontiers in Cell and Developmental Biology 4.
Crossref
Crossref
Anna E. Kersh, Maiko Sasaki, Lee A. Cooper, Haydn T. Kissick & Brian P. Pollack. (2016) Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model. Frontiers in Pharmacology 7.
Crossref
Crossref
J.M. Kim & D.S. Chen. (2016) Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure). Annals of Oncology 27:8, pages 1492-1504.
Crossref
Crossref
Davide Bedognetti, Wouter Hendrickx, Michele Ceccarelli, Lance D Miller & Barbara Seliger. (2016) Disentangling the relationship between tumor genetic programs and immune responsiveness. Current Opinion in Immunology 39, pages 150-158.
Crossref
Crossref
Elien M. Doorduijn, Marjolein Sluijter, Bianca J. Querido, Cláudia C. Oliveira, Adnane Achour, Ferry Ossendorp, Sjoerd H. van der Burg & Thorbald van Hall. (2016) TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors. Journal of Clinical Investigation 126:2, pages 784-794.
Crossref
Crossref
Patrizio Giacomini & Elisa Tremante. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology
279
296
.
JIN HONG LIU, YONG MEI BIAN, YI XIE & DAO PEI LU. (2015) Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells. Molecular Medicine Reports 12:1, pages 1059-1065.
Crossref
Crossref